The Pharmaceutical Journal
Vol 270 No 7255 p880
28 June 2003

This article
Reprint
Photocopy

News summary

Related websites
Misuse of Drugs Regulations (more)

New CDs

Remifentanil and dihydroetorphine are to be made Schedule 2 Controlled Drugs on 1 July. Gamma hydroxybutyrate and zolpidem will become Schedule 4 Part I CDs on the same date. Four steroids become Schedule 4 part II CDs (see Law and Ethics Bulletin, p910).